PDF-Jubilant Life Sciences
Noida Mon
day July
2
0 20
20
Limited announces approval
of JUBI R remdesivir
in India for the treatment of C
OVID 19
Jubilant Life Sciences Limited an integrated
Download Presentation
"Jubilant Life Sciences" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.